-+ 0.00%
-+ 0.00%
-+ 0.00%

Calidi Biotherapeutics Reports Two Posters At European Society For Medical Oncology From Its RedTail Platform

Benzinga·10/27/2026 12:04:51
Listen to the news

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ("Calidi" or "the Company"), a biotechnology company pioneering the development of targeted genetic medicines, announced that it presented two posters at the European Society for Medical Oncology (ESMO) Congress 2026 last week in Madrid. The presentations showcased new data from the Company’s RedTail platform, a systemically delivered virotherapy platform engineered to selectively target tumors, remodel the tumor microenvironment, and enable high-level expression of therapeutic genetic payloads directly within tumors.